Skip to main content

Alto Neuroscience, Inc.

ANRO
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001999480

In the last 90 days, Alto Neuroscience, Inc. insiders filed 0 open-market purchases and 1 sale; 114 institutions reported holding it in 13F filings for Q2 2026, worth $777.6M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Alto Neuroscience, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
97
+21 vs. Q3 2025
Shares held
24.5M
+7.81M (+46.9%) vs. Q3 2025
Total value
$435.9M
+$368.8M (+550.2%) vs. Q3 2025
New holders
30
27 more added
Sold out
9
25 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 97 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 53 institutionsQ2 2024: 58 institutionsQ3 2024: 75 institutionsQ4 2024: 77 institutionsQ1 2025: 83 institutionsQ2 2025: 80 institutionsQ3 2025: 77 institutionsQ4 2025: 97 institutionsQ1 2026: 110 institutionsQ2 2026: 114 institutions
Value heldQ4 2025: $435.9M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $245.2MQ2 2024: $198.8MQ3 2024: $265.5MQ4 2024: $95.3MQ1 2025: $45.0MQ2 2025: $38.1MQ3 2025: $67.4MQ4 2025: $435.9MQ1 2026: $602.5MQ2 2026: $777.6M
Institutions holding ANRO and their total value by quarter
QuarterHoldersValue
Q2 2026114$777.6M
Q1 2026110$602.5M
Q4 202597$435.9M
Q3 202577$67.4M
Q2 202580$38.1M
Q1 202583$45.0M
Q4 202477$95.3M
Q3 202475$265.5M
Q2 202458$198.8M
Q1 202453$245.2M
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Alto Neuroscience, Inc.; share changes are against Q3 2025.

Institutions holding ANRO in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Prelude Capital Management, LLC0$00.00%−11,401−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−1,450−100.0%Sold out
Advisory Services Network, LLC0$00.00%−802−100.0%Sold out
True Wealth Design, LLC0$00.00%−126−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−47−100.0%Sold out
Cloud Capital Management, LLC0$00.00%−8−100.0%Sold out
Wetherby Asset Management Inc––––Not filed